Almost $20 trillion in revenue—and a record-breaking $1.87 trillion in profits. Introducing the 2025 Fortune 500, the definitive list of the biggest companies in America.

Fortune 500

The Fortune 500, in its 70th year in 2024, ranks the biggest U.S. companies by revenue.

The Fortune 500, in its 69th year in 2023, ranks the biggest U.S. companies by revenue.

This year’s Fortune 500 marks the 68th running of the list.

This year’s Fortune 500 marks the 67th running of the list.

F500-2021-348-Genworth Financial

With origins dating back to 1871 as the Life Insurance Company of Virginia, Genworth's product offerings include long-term care insurance, mortgage insurance, and annuities. The company spent several years as part of General Electric's GE Capital division before being spun out again as an independent company in 2004. Genworth's big bet on long-term care insurance in the GE years has been a drag on its financial performance in the ensuing years, as payouts for such coverage have proved more expensive than insurers anticipated.

This year's Fortune 500 marks the 66th running of the list.

F500-2020-364-Genworth-Financial

This financial services company offers long-term care insurance as well as mortgage insurance.

This year's Fortune 500 marks the 65th running of the list.

This year's Fortune 500 marks the 64th running of the list.

This year's Fortune 500 marks the 63rd running of the list.

This year's Fortune 500 marks the 62nd running of the list.

This year's Fortune 500 marks the 61st running of the list. Wal-Mart claims the top spot again. See who made the list.

Wal-Mart stayed on top as its sales crept closer to half-a-trillion dollars. Apple moved into the top five. And UnitedHealth Group continued its steady climb. 

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Earnings Per Share (last Fiscal Year)

Earnings Per Share ($)

EPS % Change (from prior fiscal year)

EPS % Change (5 year annual rate)

EPS % Change (10 year annual rate)

Total Return

Total Return to Investors (last year)

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

Q1 2025

Q3 2024

Genworth Financial (GNW): Company Profile, Stock Price, News, Rankings

legacy

Genworth Financial

genworth financial

Good morning, ladies and gentlemen, and welcome to the Genworth Financial's Third Quarter 2024 Earnings Conference Call. My name is Lisa, and I'll be your coordinator today. At this time, all participants are in a listen only mode. We will facilitate a question and answer session towards the end of this conference call. As a reminder, this conference is being recorded for replay purposes.

Also, we ask that you refrain from using cell phones, speakerphones or headsets during Q and A portion of today's call. I'll now turn the call over to Brian Johnson, Senior Vice President of Financial Planning and Analysis. Please go ahead, sir.

Thank you, and good morning. Welcome to Genworth's Q3 2024 Earnings Call. The slide presentation that accompanies this call is available on the Investor Relations section of the Genworth website, investor. Genworth.com. Our earnings release and financial supplement can also be found there, and we encourage you to review these materials.

Speaking today will be Tom McInerney, President and Chief Executive Officer and Jerome Upton, Chief Financial Officer. Following our prepared remarks, we will open the call up for a question and answer period. In addition to our speakers, Jamala Arlund, President and CEO of our U. S. Life Insurance Business and Kelly Saltzkaefer, Chief Investment Officer, will also be available to take your questions.

During the call this morning, we may make various forward looking statements. Our actual results may differ materially from such statements. We advise you to read the cautionary notes regarding forward looking statements in our earnings release and related presentation as well as the risk factors of our most recent Annual Report on Form 10 ks as filed with the SEC. This morning's discussion also includes non GAAP financial measures that we believe may be meaningful to investors. In our investor materials, non GAAP measures have been reconciled to GAAP where required in accordance with SEC rules.

Also references to statutory results are estimates due to the timing of the filing of the statutory statements. And now, I'll turn the call over to our President and CEO, Tom McInerney.

Thank you, Brian. Good morning, everyone, and thank you for joining our Q3 earnings call. In the quarter, we continue to execute against our strategy that is driving long term growth and shareholder value.

Before I review our strategic progress, I will start with our financial performance on Slide 3. Genworth reported net income of $85,000,000 or $0.19 per share and adjusted operating income of $48,000,000 or $0.11 per share. Enact continued to lead its performance contributing $148,000,000 to adjusted operating income. We're very pleased with Enac's operational strength, capital levels and consistent shareholder distributions. On a statutory accounting basis, the U.

S. Life insurance companies reported an estimated pre tax loss of $18,000,000 driven by unfavorable mortality and higher new claims as well as lower benefits from legal settlements. Complete statutory results will be available when we file our Q3 statutory statements later this month. Our liquidity position remains strong. We ended the quarter with cash and liquid assets of $369,000,000 inclusive of approximately $162,000,000 in advanced cash payments.

Jerome will cover our financial performance by segment in more detail shortly. Throughout the quarter, we advanced each of Genworth's 3 strategic priorities as detailed on slide 4. Our first priority is to create shareholder value through Enact's growing market value and returns. We remain very pleased with our approximately 81 percent ownership of Enact, which has contributed approximately $819,000,000 in capital to Genworth since its IPO, including $81,000,000 in the 3rd quarter. Since its IPO, Enact has delivered a total shareholder return of 95% as of November 4, which relative to the S and P 500's total return of 34% over the same period of time reflects the significant value EnAct has created for Genworth shareholders.

Consistent and significant cash flows from EnAct enabled Genworth shareholder return programs. Year to date through October, we repurchased approximately 144,000,000 worth of shares, bringing our total repurchases to 503,000,000 since May of 2022. We are also using cash flows from ENACT to fuel long term growth initiatives, including our targeted investment of $35,000,000 in CareScout Services for 2024, enabling us to scale the CareScout quality and effort across the U. S. Our second strategic priority is to maintain our self sustaining customer centric LTC life and annuity legacy businesses.

Our multi year rate action plan or myRAP continues to be our most effective tool to bring our legacy LTC insurance portfolio closer to breakeven. In the Q3, we secured $124,000,000 in gross premium approvals with an average premium increase of 53%. This brings our cumulative progress to an estimated $30,000,000,000 on a net present value basis since 2012. Our advancement of the MyRAP in the Q3 included progress on our oldest products and in historically challenging states for rate actions. This progress underscores the growing recognition among legislators of their critical role in supporting LTC insurers' ability to meet policyholder obligations.

Strong progress on our myRAP as well as the LTC legal settlements and ongoing active management of our LTC business have significantly reduced and will continue to reduce the tailwinds on our legacy LTC block. This act of management enables our U. S. Life insurance company to continue to operate as a closed system, leveraging existing reserves and capital to cover future claims and other obligations. Our 3rd strategic priority is to drive future growth through CareScout with innovative consumer focused aging care services and funding solutions.

As you'll see on Slide 5, the CareScout quality network continues to scale rapidly nationwide, extending coverage to 49 states as of October 31. The network now includes 422 high quality person centered home care providers who undergo a rigorous credentialing process covering more than 20 metrics. Currently, over 90% are offering hourly rates below the Genworth median cost of care in their respective zip codes with many agreeing to 20% discounts off their standard rates. We are on track to achieve nearly 85 percent geographic coverage of the age 65 plus census population in the U. S.

By the end of this year. It is important to remember that we're still building the business with plans to expand our customer base and offerings over time. While the CareScout quality network currently includes only home care providers, we plan to add assisting living communities in large metropolitan statistical areas next year and other care types over time. In 2025, we plan to extend CareScout services to other LTC insurers policyholders and also introduce a direct to consumer offering to help families without long term care insurance find quality care at preferred rates. For our own policyholders, our goal remains to drive savings of at least $1,000,000,000 to $1,500,000,000 on LTC claims on an net present value basis over time, further mitigating risk in our legacy LTC block.

In addition to aging care services, we're developing new funding solutions for the millions of aging Americans unprepared for the cost of care. Our upcoming individual product is designed with conservative assumptions and cap coverage limits to reduce the need for LTC premium increases in the future. It will include access to our CareScout quality network, helping policyholders maximize their claim dollars. We continue to work with the Interstate Insurance Product Regulation Commission, known as the Compact, to help us secure multistate approval before launch and have completed our initial product filing. There is a significant unmet demand in the market for new and improved LTC funding products among consumers, distributors and regulators.

We are excited by our plan to reenter the market in 2025 with the goal of obtaining the required approvals in at least 25 to 35 states. Launching our new growth strategy with CareScout has been made possible by the financial flexibility we've built over the last decade, reducing debt from $4,200,000,000 as of the beginning of 2013 to $821,000,000 today. As a result of this significant achievement, as well as our unparalleled industry experience, we are uniquely positioned to capture the growing market demand for aging care services, while generating long term value for our shareholders. I look forward to sharing more about our progress in the coming quarters. Before I hand it over to Jerome, I want to take a moment to acknowledge the growing national conversation around meeting long term care challenges in our country.

As reported in our 2023 cost of care survey, the median annual cost of a home care health aid now exceeds $75,000 and a semi private room in a skilled nursing facility costs more than $100,000 per year. These figures are likely to rise significantly as the baby boomer generation ages and as the shortage of skilled workers in the space continues to pose challenges. I believe strongly in the need for public private partnerships and addressing rising LTC costs as well as the impact those costs have on our workforce as more Americans step away from their jobs to care for loved ones often to defray the high cost of care. Several states in recent years have been considering a range of funding solutions for long term care needs. At the federal level, the WISH Act championed by Representative Tom Swayze aims to create a federal LTC program funded by our payroll tax to help Americans manage long term care costs.

More recently, both U. S. Presidential candidates included long term care related policy proposals in their agendas. While each of these proposals presents its own benefits and challenges, their emergence is an encouraging sign that our nation is increasingly recognizing and addressing the long term care crisis. We remain committed to engaging with the states, Congress and the next administration to advance responsible, effective solutions.

In closing, I am proud of our ongoing progress against our strategic priorities and the strong performance we continue to see from EnAct. With that, I'll turn the call over to Jerome for a deeper discussion of our financial results.

Thank you, Tom, and good morning, everyone. I'm pleased with Enac's continued strong operating performance, the progress on our MIRAP, our debt optimization and the capital returns we delivered in the quarter. I'll first discuss Genworth's financial results and drivers in more detail, then I'll provide a preview of our U. S. Life 4th quarter assumption review process, followed by an update on our investment portfolio and holding company liquidity before we open the call for Q and A.

As shown on Slide 6, 3rd quarter adjusted operating income was $48,000,000 driven primarily by an act. Our Long Term Care Insurance segment reported an adjusted operating loss of $46,000,000 This was driven by a liability remeasurement loss from actual to expected experience, partially offset by favorable cash flow assumption updates related to IFA approval amounts. As a reminder, actual to expected experience drives GAAP results in LTC and fluctuates quarterly, including from seasonal mortality trends. For the full year, we continue to expect a liability remeasurement loss from actual to expected experience. Going forward, we expect continued GAAP earnings volatility in LTC as short term results deviate from long term assumptions.

The strong results from EnAct were partially offset by adjusted operating losses of $27,000,000 in life and annuities and $27,000,000 in corporate and other. Within life and annuities, life insurance posted an adjusted operating loss of $40,000,000 driven by unfavorable mortality. This was partially offset by adjusted operating income of $6,000,000 from fixed annuities and $7,000,000 from variable annuities. Corporate and Other reported a $27,000,000 loss driven by interest expense on holding company debt and growth investments in CareScout. Sequentially, Corporate and Other was primarily impacted by the timing of tax related items.

Now taking a closer look at ENACT's performance on Slide 7. ENACT delivered another strong quarter with $148,000,000 in adjusted operating income, a 10% year over year increase reflecting reserve releases driven by continued favorable cure performance alongside strong net investment income. Primary insurance in force grew 2% year over year to 268,000,000,000 supported by new insurance written and continued elevated persistency. As shown on Slide 8, EnAct's favorable $65,000,000 pre tax reserve release drove a loss ratio of 5%. ANAC's PMIER sufficiency ratio remains strong at 173 percent or approximately $2,200,000,000 above requirements.

Genworth's share of ANAC's book value, including AOCI, has increased to $4,100,000,000 at the end of the Q3 of 2024, up from $3,800,000,000 at year end 2023, while at the same time, Enak has delivered significant capital returns to Genworth. The combination of EnAct's quarterly dividend and its share repurchase program generated a total of $81,000,000 in proceeds to Genworth in the 3rd quarter. We now expect total capital returns from Enac to be in the upper end of our $245,000,000 to $285,000,000 guidance range for the full year, further supporting our capital allocation priorities, which I will detail shortly. On Slide 9, we highlight the significant progress made on our MIRAT. As Tom mentioned, this includes successful rate actions on our oldest product and in states historically slow to approve increases.

As we work to stabilize the legacy LTC block and protect our claims paying ability, the premium rate increases and associated benefit reductions from the MIRAP as well as legal settlements have significantly reduced tail risk. As of the end of Q3, we have achieved approximately $30,000,000,000 of in force rate actions on a net present value basis with a cumulative policyholder response rate of nearly 57% choosing to reduce benefits. Slide 10 shows that we secured $124,000,000 in IFA approvals on a gross incremental basis in the Q3, bringing the year to date total to 303,000,000 dollars We also submitted $172,000,000 in in force premium filings in the quarter, bringing the year to date total to $276,000,000 Based on strong approvals in prior years, we expect that total in force premium filings submitted this year will be lower compared to prior years. We are pleased with the continued success of the MIRAP, which remains our most

effective tool for ensuring the long term self sustainability of

our legacy life insurance companies. As we've said before, we believe statutory results better represent the underlying economics of the LTC business as they reflect the positive impacts of our in force rate actions and legal settlements. As shown on Slide 11, in force rate actions and legal settlements had a $1,300,000,000 pretax benefit to LTC statutory income year to date, dollars 199,000,000 higher than the same period last year. The increase is primarily driven by the net favorable impacts of the 3rd and final legal settlement, which began in the Q2 of 2023. The favorable impact is expected to continue to trend downward into the Q4 as the final settlement activities come to a conclusion.

Slide 12 shows our pre tax statutory results for the U. S. Life insurance companies. On a year to date basis, we generated pre tax income of $411,000,000 In the Q3, we had a loss of $18,000,000 down from income in the prior quarter due to a smaller benefit from LTC legal settlements, higher LTC claims and unfavorable mortality in the life and annuity products. Statutory earnings drove a consolidated risk based capital ratio for Genworth Life Insurance Company or GLIC of 3 17% at the end of September compared to 3 19% at the end of June and 3 0 3 percent at the end of 2023, reflecting our strong statutory earnings year to date.

The quarter over quarter change is driven by a slight increase in required capital as we continue to grow our limited partnership portfolio. Glick's consolidated balance sheet remains sound with capital and surplus of $3,700,000,000 as of the end of September. Our final statutory results will be available on our investor website with our Q3 filings later this month. As we look ahead, I'd like to discuss our approach to this year's annual assumption review, which will be completed in the Q4. While our review is still ongoing, we have been monitoring key trends and can provide some preliminary perspectives.

In LTC, our review is focused on short term trends and key assumptions such as benefit utilization, incidence, mortality and in force rate actions. For our life and annuity products, we are reviewing mortality, lapse rates and the potential impacts of the recent decline in interest rates. As a reminder, our assumption updates for our LTC, life and annuity products in the aggregate in Q4 2023 resulted in a negative impact to pre tax GAAP earnings of approximately $300,000,000 While our review is not yet complete, our preliminary view is the impacts from the assumption updates in the aggregate would be in a similar range for GAAP as the prior year. In parallel with the assumption review, we are conducting statutory cash flow testing for our life insurance companies. While this process is not yet complete, our initial assessment indicates that Glick's margin should remain positive.

Additionally, certain of our universal life secondary guarantee products require additional statutory reserve testing using the regulatory prescribed reinvestment rate for the period from July 2023 to June 2024. Given that interest rates were higher during this period compared to the prior year, we expect a favorable impact from the reinvestment rate. From a statutory income perspective, we believe the reinvestment rate benefit will help offset any potential negative impacts from the assumption updates. The prior year impact was materially favorable given the significant increase in the prescribed reinvestment rate. We will discuss the results of our assumption reviews and statutory cash flow testing on our Q4 earnings call.

As we've said before, we manage the U. S. Life insurance companies on a standalone basis. They operate as a closed system using existing reserves and capital to meet future claims and obligations. We will not put capital into the legacy life insurance companies and given the long tail nature of our LTC insurance policies with peak claim years still at least a decade away, we do not expect capital returns from these companies.

Turning to Slide 13. Our investment portfolio remains strong. The majority of our assets are in investment grade fixed maturities held to support our long duration liabilities. New investments during the quarter achieved yields of 5.8% and our alternative assets program continues to generate strong returns targeting approximately 12%. We maintain confidence in our commercial real estate exposure, which accounts for approximately 15% of the portfolio and is concentrated in high quality investment grade assets with less than 20% office exposure.

Next, turning to the holding company on Slide 14. We received $81,000,000 in capital from ANAC and ended the quarter with $369,000,000 of cash and liquid assets. Included in our cash and liquid assets, we hold approximately $162,000,000 of advanced cash payments from our subsidiaries for future obligations. We do not consider this cash when evaluating holding company liquidity for the purposes of capital allocation or calculating the buffer to our debt service target. Tom reviewed our capital allocation strategy and I'll reiterate that our top priorities shown on Slide 15 are to invest in long term growth through CareScout, return cash to shareholders through our share repurchase program when our share price is below intrinsic value and opportunistically pay down debt when attractive to us.

We continue to return capital to shareholders through share repurchases in the Q3, repurchasing $36,000,000 of shares at an average price of $6.38 per share and another $10,000,000 through the end of October. We have $197,000,000 remaining under our current authorization as of the end of October and now expect to allocate between $160,000,000 to $180,000,000 to share repurchases in 2024. Our final amount for the full year may vary depending on our share price and market conditions. And as a reminder, the amount will be lower than we repurchased in 2023 given that we have fully utilized our holding company tax assets. Since the initial authorization in May of 2022, we have reduced outstanding shares by 16% from approximately 511,000,000 shares to 427,000,000 shares outstanding as of the end of October.

We're very pleased with the value created for shareholders through our share repurchase program. We also retired $17,000,000 of principal debt in the 3rd quarter for $15,000,000 in cash. Year to date, we have retired $35,000,000 of principal debt, bringing our total holding company debt to $821,000,000 Our debt to capital ratio is well below 25%, attributing no equity value to LTC, life and annuities. Additionally, we executed $100,000,000 interest rate swap on our subordinated floating rate debt, locking in an approximate 5.5% yield to manage interest rate risk more effectively. We are pleased with our financial flexibility given our liquidity level, sustainable cash flows from EnAct and manageable debt level.

In closing, we are delivering on our strategic priorities while proactively managing our liabilities and risk. The multi year rate action plan and the additional benefit from the 3 LTC legal settlements are further stabilizing the legacy LTC block. Enact is a key driver of shareholder value as evidenced by its strong earnings, increasing book value and increased capital returns. Looking ahead, we will continue to focus on delivering sustainable long term growth through Enact and CareScout, while returning meaningful value to shareholders through share repurchases and opportunistically repurchasing holding company debt. Now let's open up the line for questions.

Ladies and gentlemen, we will now begin the Q and A portion of the call. And our first question comes from Brett Ozettek with KBW.

Hey, good morning. My first one is on the AXA Santander lawsuit. I think the case is still set for March of next year, but if there is a positive ruling for you guys there, could you just comment on the potential use of proceeds?

Brett, thank you very much for the question. So yes, the trial date is still set for March of 2025. It's possible there could be a settlement before then, but that's the March date. To the extent that we win that case and we've been saying for a long time, we think we like our side of or the access side of that lawsuit. And I think the focus for any proceeds would be to continue to do what we've been doing, return capital to shareholders through the share repurchase program.

I think you'd see us step up that in any way. We'll continue where there's good opportunities, a good pricing to buy back the data. And then obviously, we want to continue to invest in CareScout, both CareScout Services business, which as both Jerome and I talked about is doing very well, gaining very good momentum. And then also investing in the new CareScout Insurance business when we launched the first product sometime next year. Jerome, I don't know if you want to add anything to that.

Okay, great. Thanks. And then for my follow-up, I was just hoping you guys could give a little more color on how the CareScout revenue model will work beyond potential savings on LTC claims?

Yes. So basically, maybe just to try to make it simple, Brett. It's a good question. But as I said in my remarks, the annual cost for home care is about $75,000 a year. So let's say, roughly a little over $6,000 a month.

And we're doing very well on the discounts, I think 90% or in the 20% range. So if you do say the savings through the discount on the GLIC policy, so $1,000 a month, dollars 250,000 of that goes to CareScout Services because they've built and maintained the network. And then $750,000,000 of the $1,000 a month savings is retained by Glick in terms of lower claim costs. So that's the basic model.

Okay, great. Thank you. Okay, great. Thank you. Yes.

And we'll move to our next question from Joshua Esterov with CreditSights.

Hello, good morning. Thank you for taking the time. I've got two questions on CareScout. The first one is maybe more of a clarifying question. And that's how do you define coverage percentage in your presentation material?

Is that as straightforward as you have just at least one care provider in the zip code where age 65 plus individuals are located? And then separately, before I hop back into the queue, how do either the insurer or the policyholder become aware that there are services available to them at potentially lower prices, especially with regards to non generic policyholders?

Those are great questions, Josh. And so the first one in terms of CareScout, we look at the coverage by zip code. And so depending obviously, you would expect in those zip codes in bigger cities, there'll be several providers in the network in that area. As you get to the more rural areas, I mentioned we were in 49 states. The one state we're not fully in yet is Wyoming, obviously, it's a more rural state.

So there obviously are zip codes that are where they're less populated and therefore there are less 65 plus year olds and less Genworth policyholders. So on those zip codes, it would probably more typical that you might only have 1, maybe 2 providers. So that's basically how it works. And the second question the second part of the question was?

Touch points with insurance and policyholders.

Yes. So touch points with insurance and policyholders. For our policyholders, we obviously communicate with them regularly. And we have been since we started the journey with CareScout Services, have been telling them about the network. When someone files a claim, obviously, we work to assess the claim, determine if coverage applies.

And through that process, which takes on average 20 to 30 days, we'll talk about who are the providers in the network, the discounts they provide and that's how it's done. The last several months with the click policyholders, we've been doing more than 100 per month of matches between the policyholder going on claim in the network. For the direct to consumer, we'll be from a broader perspective, we'll be marketing that this network is available, it's available in these states. We most of the providers are below the median cost of care in the state or the zip code and we credential for quality on 20 different dimensions. So I think our whole value proposition there is we're taking all of the time and effort to find a provider away from the person needing care or typically their family.

And at the same time, whatever the rate would be per hour for home care, again, generally, we're getting significant discounts. 20% is sort of then where we've been out for most of the policyholders. Obviously, for the direct to consumer, where they don't have insurance, the savings are very significant since they're paying. So we're very optimistic going forward. We got to first complete the network.

We said by the end of the year, we want to be at 85 percent coverage. That's for practical purposes, that's pretty full coverage. There are always going to be whether it's Wyoming or Montana, Idaho, other states like that, where we'll take time to fill in the gaps. So we think at 85% that will be pretty much effective nationwide coverage. And once we have that, we'll then begin to accelerate our marketing plans to let consumers in general know that the network's available.

Appreciate that. Thanks. Thank you, Josh.

And we'll move to our next question from Douglas Smith with Everest Group.

Good morning. I'd also like to focus on CareScout for a moment from understanding better how the identity impacts the parent company as opposed to what's going on in the ring fenced insurance entities. I assume all the expenses of CareScout are in the parent company level and that I'm trying to understand currently what the offsetting revenue might be and kind of what the P and L looks like, if you will, on a standalone basis?

So, Doug, good morning and thanks for your question. I would start out by saying and Tom highlighted in his prepared remarks that we are investing $35,000,000 in the CareScout Services business. That is all contained in the corporate and other segment

So that you will see coming through and that's why we've highlighted the $35,000,000 for you. So you can understand the investment we're making. We are going after a very large market as Tom highlighted. So we're optimistic about what we're doing there. So expenses are in corporate and other.

On the revenue side, CareScout Services when they are saving our GLIC policyholders money because the providers are signing up for 90% or signing up for like a 20% discount. CareScout Services would get 25% of that, and that would come in the corporate and other as well. So it's mostly contained in the corporate and other segment. And are there material revenues in corporate and other offsetting a significant portion of that expense run rate? So there are revenues coming through on the assessment side, which is a service that is provided to GLIC.

However, when you have those assessments and they come through from GLIC and consolidation, we eliminate that revenue. There are some matches that are being made where there's a fee stream coming through from the GLIC policyholders. But at this point in time, given the newness of the business, those revenue streams are pretty small. And the $35,000,000 run rate would be net of whatever that offsetting revenue might be?

And then if CareScout did initiate an insurance product, would that be inside or outside of the ring fenced insurance entities?

Another good question. That would be outside. So basically think of you have the parent holding company and it owns the EnAct and it and its share of EnAct and the legacy life companies. And then separately, so a sister entity would be CareScout Inc, call that the holding company of CareScout. And then underneath that holding company will be CareScout Services.

That's the service business and it's a fee business, not very capital intensive. And as you've mentioned, Doug, the ultimately will be the revenues from our share of the discounts, whether it's a good general policyholder, other insurers, policyholders, which and we're talking to several other closed block LTC players on allowing their policyholders to use the network and take advantage of the discounts. And then when we go to consumers, it would be the same type of model that whatever that monthly savings is for home care, as I said, that's around $1,000 a month, we'll negotiate a fee for CareScout services. But obviously, a significant part of that $1,000 a month savings will accrue to the benefit of either the policy holder if they have insurance. And if they don't, then they're paying the cost.

And so they'll get the significant part or the majority part of the discount. So clearly, the goal is to have as many matches where we brought a policyholder or consumer with a provider and the 25% that goes to CareScout Services. Obviously, in order to cover, you can do the math, 30 if we're saving if it's $250 a month out of the $1,000 typically our claims are a couple of years, plus or minus. So it's about for the CareScout services, share of that would be $2.50 a month. So basically $3,000 a year.

So you can calculate how many matches you need, whether there are policyholders, other insurance policyholders or consumers in order to cover that $35,000,000 investment. So it's a scale business. We're still completing the network. It usually takes about 90 days after you have a state or a zip code cover where you start to get batches. So we're very optimistic that this will ultimately be a very good business for us given that we've got 70,000,000 baby boomers and the oldest of those that are 78 this year in 2 years they'll be they'll start to turn 80 almost 10,000 a day will turn 80 and early 80s is when the peak time years are.

I just add? Doug, the one thing that I think are implied would be implied in both my comments and Tom's comments around CareScout Services is we are saving claims. There's claim savings coming through for the GLIC policyholders. And I think we articulated on the slide over time, we expect that to be meaningful to GLIC, the $1,000,000,000 to $1,500,000,000 So while we're building scale, we are going to be saving the GLIC policyholders money and GLIC money. And that's $1,000,000,000 to $1,500,000,000

And our next question comes from Joshua Esterov with CreditSights.

Hey, guys. Thank you again for taking another one for me. In your prepared remarks on the Q4 LCC reserve review, you made note that you expect Glick's reserve margin to remain positive. Can you please remind us either where that margin is currently or where it was the last time you provided an update?

Yes. Thank you for your question, Joshua. When we did our cash flow testing, our statutory review of margin at year end 2023, we were in the $500,000,000 to $1,000,000,000 range for stat margin, and we do expect to maintain our statutory margin for Glick in that same range this year.

And ladies and gentlemen, it appears that there are no questions at this time. I will now turn the call back over to Mr. McInerney for closing comments.

Thank you very much, Lisa. I want to again thank Brad, Josh and Doug for their questions. I think there are questions that a lot of our investors have. So it was a good opportunity for us to elaborate a little bit more on that. We're very pleased with where we are, obviously, and that continues to perform extremely well.

Solid earnings, good return of capital through their regular dividends to us as well as on the share buybacks. So we're pleased with that. The 3 priorities we talked about, we're making good progress on that, which is addition to expanding the value of an act for our shareholders. We're also making good progress with our legacy LTC business in terms of the MyRap, very, very good results. And then finally, as we talked about and had some questions on, we're really scaling up the CareScout business and we're looking very forward to significant growth in that business in 2025 and beyond.

So with that, Lisa, I'll turn the call back to you to end the call.

Ladies and gentlemen, this concludes Genworth's Financial Third Quarter Conference Call. Thank you for your participation. At this time, the call will end.

Genworth Financial Q3 2024 Earnings Call Transcript | Fortune

Nino Paoli

Davenport, Florida, Starbucks Coffee, outside exterior drive thru through.

Starbucks hops on the health craze with protein coffee weight-loss influencers had been concocting in its drive thru for months

/2025/09/04/starbucks-protein-coffee-cold-foam-launch-september-29-health-trend-gen-z-glp1-tiktok-functional-beverages-wellness-menu-innovation/

John Kell

With 100 Gen AI pilot projects but just six in production, Carnival Cruise Line’s CIO takes a measured approach to artificial intelligence journey

/2025/09/03/with-100-gen-ai-pilot-projects-but-just-six-in-production-carnival-cruise-lines-cio-takes-a-measured-approach-to-artificial-intelligence-journey/

Genworth Financial (GNW) Q3 2024 Earnings Call Transcript

Company Participants